Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO
- Status
- COMPLETED
- Phase
- PHASE2
Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC
- Status
- COMPLETED
- Phase
- PHASE2
PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Palbociclib After CDK and Endocrine Therapy (PACE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE2
Metastatic Breast Cancer Treatment Planning
- Status
- WITHDRAWN
- Phase
- NA
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
- Status
- TERMINATED
- Phase
- N/A
"Curcumin" in Combination With Chemotherapy in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Open-label Study of Safety, Tolerability and Pharmacokinetics of Multiple Doses of BI-CON-02 in Patients With HER2-positive Metastatic Breast Cancer, Previously Treated With Trastuzumab
- Status
- TERMINATED
- Phase
- PHASE1
Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
- Status
- TERMINATED
- Phase
- PHASE2
A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient
- Status
- COMPLETED
- Phase
- NA